Search

everythinglearnresearchcommunity

for

Search:↓

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Gefitinib can cause hair loss without scarring.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Erythropoietin overexpression disrupts hair growth and fat formation in mice.

A new therapy for a skin blistering condition has not been developed yet.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

The device improved hair growth and thickness in men without side effects.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Arsenic trioxide effectively treats APL, improving survival rates despite its toxicity.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

The serum with microneedling device improves hair loss treatment effectively and safely.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.